_page-00019.jpg)
_page-00018.jpg)
_page-00011.jpg)
Email this article ASSOCIATION BETWEEN FASTING BLOOD GLUCOSE AND C-REACTIVE PROTEIN LEVELS IN TYPE 2 DIABETES MELLITUS PATIENTS
Abstract
Background: Diabetes mellitus (DM) is characterized by elevated blood glucose levels resulting from decreased insulin secretion by pancreatic beta cells. Fasting blood glucose (FBG) measurement is commonly used to monitor DM, requiring patients to fast for a minimum of eight hours. Insufficient insulin production impairs glucose uptake into body tissues, leading to hyperglycemia. Chronic hyperglycemia subsequently stimulates the production of inflammatory cytokines, which promotes the hepatic synthesis of C-reactive protein (CRP).
Objective: This study aims to determine the relation between FBG and CRP levels in patients with type 2 diabetes mellitus (T2DM) at Mangusada Hospital.
Method: An observational analytic study was conducted using purposive sampling, with a total sample of 25 T2DM patients.
Result: The lowest FBG level was 126 mg/dL, while the highest was 319 mg/dL. The lowest CRP level was 0.2 mg/L, whereas the highest was 23.7 mg/L. High FBG and CRP levels were observed in 44% of respondents, while high FBG with normal CRP levels were found in 56%. The highest FBG (319 mg/dL) also exhibited the highest CRP level (23.7 mg/L) The non-parametric Spearman’s rank correlation revealed a significant association between FBG and CRP levels with p-value of 0.012 (<0.05) and r = 0.493 indicated a positive and moderate correlation.
Conclusion: There is a positive, moderate correlation between FBG and CRP levels in T2DM patients at Mangusada Hospital.
Keywords
C-Reactive Protein, blood glucose, diabetes
Full Text:
PDFReferences
Goldberg I, Shalmon D, Shteinvil R, Berliner S, Paran Y, Zeltser D, et al. A second C-reactive protein (CRP) test to detect inflammatory burst in patients with acute bacterial infections presenting with a first relatively low CRP. Medicine (Baltimore). 2020 Oct;99(42):e22551.
Magliano DJ, Boyko EJ, Committee IDA 10th edition scientific. IDF DIABETES ATLAS [Internet]. 10th editi. Brussels: International Diabetes Federation; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK581934/
Kementerian Kesehatan Republik Indonesia. Laporan Nasional Riskesdas 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan; 2019.
Dinas Kesehatan Provinsi Bali. Profil Kesehatan Provinsi Bali Tahun 2021. Denpasar Bali: Dinas Kesehatan Provinsi Bali; 2021.
Rahman MM, Kamal AHM, Mollah FH, Hafiz MG, Arsian MI. Association of C-reactive Protein with Fasting Blood Glucose in Newly Diagnosed Type 2 Diabetes Mellitus Patients. Bangladesh J Pathol [Internet]. 2010 Jan 8;24(2 SE-Original Articles):4–7. Available from: https://www.banglajol.info/index.php/BJPath/article/view/4110
Ahmad S, Kadadi S, Pratap PD, Nishtha Bassi, Sheikh I, Raza A. Association Between C - Reactive Protein And Fasting Blood Glucose In Type 2 Diabetes Mellitus Patient. Int J Acad Med Pharm. 2023;5(1):653–6.
Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, Gong CX, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018 Oct;19 Suppl 27(Suppl 27):7–19.
Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet (London, England). 2017 Jun;389(10085):2239–51.
Missel AL, Saslow LR, Griauzde DH, Marvicsin D, Sen A, Richardson CR, et al. Association between fasting insulin and C-reactive protein among adults without diabetes using a two-part model: NHANES 2005-2010. Diabetol Metab Syndr. 2021 Mar;13(1):29.
Shim K, Begum R, Yang C, Wang H. Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus. World J Diabetes. 2020 Jan;11(1):1–12.
Singh B, Goyal A, Patel BC. C-Reactive Protein: Clinical Relevance and Interpretation. Treasure Island (FL): StatPearls Publishing. 2025.
Stanimirovic J, Radovanovic J, Banjac K, Obradovic M, Essack M, Zafirovic S, et al. Role of C-Reactive Protein in Diabetic Inflammation. Mediators Inflamm. 2022;2022:3706508.
Babu LE, Joshi A. Correlation of high-sensitivity C-reactive protein with blood sugar level in patients with Type 2 diabetes. Natl J Physiol Pharm Pharmacol. 2018;8(1):37–41.
Suardi, Arisanti D, Hasnah, Kai KW. Deteksi C-Reactive Protein ( CRP) Pada Penderita Diabetes Melitus ( DM ) di RSUD Labuang Baji Kota Makassar. J Med Media Ilm Anal Kesehat. 2023;7(2):55–60.
Kapero FW, Mahtuti EY, Rahmawati PZ. Description Of C-Reactive Protein ( CRP ) In Patients With Type 2 Diabetes Mellitus At Mulyorejo Health Center In Malang City. J Anal Med Biosains(JAMBS). 2023;10(2):75–81.
Pan A, Wang Y, Yuan JM, Koh WP. High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study. BMC Endocr Disord. 2017 Feb;17(1):8.
Tian T, Wei B, Wang J. Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis. BMC Emerg Med. 2021 Jul;21(1):81.
Zhou HT, Zhao DL, Wang GK, Wang TZ, Liang HW, Zhang JL. Assessment of high sensitivity C-reactive protein and coronary plaque characteristics by computed tomography in patients with and without diabetes mellitus. BMC Cardiovasc Disord. 2020 Oct;20(1):435.
Kanmani S, Kwon M, Shin MK, Kim MK. Association of C-Reactive Protein with Risk of Developing Type 2 Diabetes Mellitus, and Role of Obesity and Hypertension: A Large Population-Based Korean Cohort Study. Sci Rep. 2019 Mar;9(1):4573.
Socha MW, Malinowski B, Puk O, Wartęga M, Bernard P, Nowaczyk M, et al. C-reactive protein as a diagnostic and prognostic factor of endometrial cancer. Crit Rev Oncol Hematol. 2021 Aug;164:103419.
DOI: https://doi.org/10.33992/meditory.v13i2.4903
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Komang Ayu Aishvarya Gangga Devi, Caroline Ester Sewar, Luh Ade Wilan Krisna
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.